Handelsbanken Fonder’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-26,400
Closed -$198K 1574
2024
Q3
$198K Hold
26,400
﹤0.01% 1495
2024
Q2
$235K Buy
26,400
+3,900
+17% +$34.7K ﹤0.01% 1456
2024
Q1
$228K Hold
22,500
﹤0.01% 1478
2023
Q4
$226K Buy
22,500
+9,300
+70% +$93.4K ﹤0.01% 1488
2023
Q3
$124K Hold
13,200
﹤0.01% 1529
2023
Q2
$324K Buy
13,200
+100
+0.8% +$2.46K ﹤0.01% 1309
2023
Q1
$305K Buy
+13,100
New +$305K ﹤0.01% 1282
2022
Q4
Sell
-11,000
Closed -$212K 1614
2022
Q3
$212K Hold
11,000
﹤0.01% 1416
2022
Q2
$280K Sell
11,000
-800
-7% -$20.4K ﹤0.01% 1365
2022
Q1
$303K Buy
11,800
+600
+5% +$15.4K ﹤0.01% 1513
2021
Q4
$469K Buy
11,200
+1,600
+17% +$67K ﹤0.01% 1394
2021
Q3
$418K Hold
9,600
﹤0.01% 1453
2021
Q2
$454K Sell
9,600
-2,700
-22% -$128K ﹤0.01% 1448
2021
Q1
$631K Hold
12,300
﹤0.01% 1069
2020
Q4
$329K Hold
12,300
﹤0.01% 1361
2020
Q3
$422K Buy
+12,300
New +$422K ﹤0.01% 1078